ZNF773 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 4.99711383383783E-13 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.5823999999508E-06 |
Normal-vs-Stage2 |
1.225780E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
9.005200E-04 |
Stage1-vs-Stage2 |
2.429000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
7.287900E-02 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.305000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.24690307762899E-11 |
Normal-vs-AfricanAmerican |
2.081600E-01 |
Normal-vs-Asian |
2.224400E-02 |
Caucasian-vs-AfricanAmerican |
1.135420E-01 |
Caucasian-vs-Asian |
4.649200E-01 |
AfricanAmerican-vs-Asian |
4.299400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.80309999999939E-05 |
Normal-vs-Female |
2.53569998331926E-09 |
Male-vs-Female |
4.243700E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.593950E-04 |
Normal-vs-Extreme_Weight |
9.58580000000042E-05 |
Normal-vs-Obese |
2.157600E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
9.870000E-01 |
Normal_Weight-vs-Obese |
4.939400E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
5.897400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.949030E-01 |
Normal-vs-Age(41-60Yrs) |
8.957500E-04 |
Normal-vs-Age(61-80Yrs) |
4.89419949012415E-10 |
Normal-vs-Age(81-100Yrs) |
2.998400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.219220E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.021800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.518760E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.835500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.626200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.643700E-02 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
4.837400E-01 |
Normal-vs-Grade 3 |
5.479600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.901600E-01 |
Grade 2-vs-Grade 4 |
4.837400E-01 |
Grade 3-vs-Grade 4 |
5.479600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.45270043059054E-10 |
Normal-vs-N1 |
3.259100E-03 |
N0-vs-N1 |
1.824400E-02 |
|
|